SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: squetch who wrote (10475)10/30/1997 11:20:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
<<Any talk of LGND up in
Boston, as BU owned 75% of it at end of '96?>>

Stan, Probably a better question would be "Any talk of SRGN at the Oppenheimer Conference this week?" because it sounds like the announcement on the compound will come in less than 2 weeks and if its SRGN's DAB IL-2 fusion protein, then the deal should be just about "done" (and all of LGND's heavy hitters are hanging around the East coast).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News